• 1
    Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand's disease: variability versus “variants”. Blood 1980;56:712716.
  • 2
    Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood 1979;54:117136.
  • 3
    Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease. II. Optimal assignment of the heterozygous genotype (diagnosis) by discriminant analysis. Blood 1979;54:137145.
  • 4
    Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985;37:89101.
  • 5
    Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:16911695.
  • 6
    Rodeghiero F, Castaman G, Tosetto A. von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease—results based on an epidemiological investigation. Thromb Haemostasis 1990;64:349352.
  • 7
    Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993;123:893898.
  • 8
    Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemostasis 1993;70:380385.
  • 9
    Green D, Ruth KJ, Folsom AR, Liu K. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb 1994;14:686693.
  • 10
    Dilley A, Drews C, Miller C, Lally C, Austin H, Ramaswamy D, Lurye D, Evatt B. von Willebrand disease and other inherited bleeding disorders in women diagnosed with menorrhagia. Obstet Gynecol (in press).
  • 11
    Goodall AH, Jarvis J, Chand S, Rawlings E, O'Brien DP, McGraw A, Hutton R, Tuddenham EG. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope. Br J Haematol 1985;59:565577.
  • 12
    Murdock PJ, Woodhams BJ, Matthews KB, Pasi KJ, Goodall AH. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Thromb Haemostasis 1997;78:12721277.
  • 13
    Miller CH, Dilley A, Evatt B. Disproportionately high factor VIII activity levels in normal study subjects using the 3rd International Plasma Standard. Thromb Haemostasis (in press).
  • 14
    Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptives. Thromb Haemostasis 1999;82:14561461.
  • 15
    Mackie I, Bull H, Kennedy J, Brozovic M. Ristocetin-induced platelet agglutination in Afro-Caribbean and Caucasian people. Br J Haematol 1982;50:171173.
  • 16
    Colonia VJ, Roisenberg I. Investigation of associations between ABO blood groups and coagulation, fibrinolysis, total lipids, cholesterol, and triglycerides. Hum Genet 1979;48:221230.
  • 17
    Gomperts ED, Fatti LP, van der Walt JD, Feesey M, Hartman E, Snell RJ. Factor VIII and factor VIII related antigen in normal South African blacks and a black carrier group. Thromb Res 1976;9:293299.
  • 18
    Werner EJ, Abshire TC, Giroux DS, Tucker EL. The relative value of diagnostic studies for von Willebrand disease. J Pediatr 1992;121:3438.
  • 19
    Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998;351:485489.
  • 20
    Buchanan GR, Holtkamp CA, Levy EN. Racial differences in ristocetin-induced platelet aggregation. Br J Haematol 1981;49:455464.
  • 21
    Matsui T, Fujimura Y, Nishida S, Titani K. Human plasma α2-macroglobulin and von Willebrand factor possess covalently linked ABO (H) blood group antigens in subjects with corresponding ABO phenotype. Blood 1993;82:663668.
  • 22
    White RH, Zhou H, Romano PS. Incidence of idiopathic deep vein thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998;128:737740.
  • 23
    Austin H, Hooper WC, Dilley A, Drews C, Renshaw M, Ellingsen D, Evatt B. The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans. Thromb Res 1997;86:409415.
  • 24
    Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152155.
  • 25
    O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemostasis 2000;83:1013.